References
- Laird DW, Fistouris P, Batist G, Alpert L, Huynh HT, Carystinos GD, Alaoui-Jamali MA (1999). Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Res 59: 4104–4110.
- Qin H, Shao Q, Curtis H, Galipeau J, Belliveau DJ, Wang T, Alaoui-Jamali MA, Laird DW (2002). Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J Biol Chem 277: 29132–29138.
- Qin H, Shao Q, Igdoura S, Alaoui-Jamali M, Laird D (2003). Lysosomal and proteasomal degradation play distinct roles in the life cycle of Cx43 in gap junctional intercellular communication-deficient and -competent breast tumor cells. J Biol Chem 278: 30005–30014.
- Jordan K, Solan JL, Dominguez M, Sia M, Hand A, Lampe PD, Laird DW (1999). Trafficking, assembly, and function of a connexin43-green fluorescent protein chimera in live mammalian cells. Mol Biol Cell 10: 2033–2050.
- Laird DW, Jordan K, Thomas T, Qin H, Fistouris P, Shao Q (2001). Comparative analysis and application of fluorescent protein-tagged connexins. Microsc Res Tech 52: 263–272.
- LairdDW, Castillo M, KasprzakL(1995). Gap junction turnover, intracellular trafficking, and phosphorylation of connexin43 in brefeldin A-treated rat mammary tumor cells. J Cell Biol 131: 1193–1203.
- Hirschi KK, Xu CE, Tsukamoto T, Sager R (1996). Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ 7: 861–870.
- Shimo T, Nakanishi T, Nishida T, Asano M, Sasaki A, Kanyama M, Kuboki T, Matsumura T, Takigawa M (2001). Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis. Oncology 61: 315–322.
- Tsai MS, Bogart DF, Castaneda JM, Li P, Lupu R (2002). Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene 21: 8178–8185.
- Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL, Boynton AL (1998). Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res 58: 5089–5096.
- Reiher FK, Volpert OV, Jimenez B, Crawford SE, Dinney CP, Henkin J, Haviv F, Bouck NP, Campbell SC (2002). Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics. Int J Cancer 98: 682–689.
- McLeod TL, Bechberger JF, Naus CC (2001). Determination of a potential role of the CCN family of growth regulators in connexin43 transfected C6 glioma cells. Cell Commun Adhes 8: 441–445.
- Naus CC, Bond SL, Bechberger JF, Rushlow W (2000). Identification of genes differentially expressed in C6 glioma cells transfected with connexin43. Brain Res Brain Res Rev 32: 259–266.